# Regadenoson

NDC: 60505-6288
Generic name: regadenoson
Labeler / Manufacturer: Apotex Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250403

FDA application: ANDA207604

## Active ingredients

- REGADENOSON: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-6288"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-6288
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88909dc6-502a-61b1-b8e1-22a42da65847